Login / Signup

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial.

Maxime DesmaretsSimone HoffmannCharline VauchyBart J A RijndersEric ToussirotAntoine DurrbachSixten KörperEva SchrezenmeierC Ellen van der SchootHeli HarvalaGaëlle BrunotteThomas ApplErhard SeifriedPierre TiberghienDaniel BradshawDavid J RobertsLise J EstcourtHubert Schrezenmeier
Published in: BMJ open (2023)
Clinical Trials.gov (NCT05271929), EudraCT (2021-006621-22).
Keyphrases
  • clinical trial
  • open label
  • phase ii
  • phase iii
  • study protocol
  • coronavirus disease
  • sars cov
  • phase ii study
  • double blind
  • randomized controlled trial
  • placebo controlled
  • stem cells
  • squamous cell carcinoma
  • bone marrow